Scott A. Campbell Insider Trading $CPHD CEPHEID
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott A. Campbell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott A. Campbell. Scott A. Campbell is Corporate VP & CRO in CEPHEID ($CPHD) and VP, Clinical Affairs & CRO in CEPHEID ($CPHD).
Scott A. Campbell in CEPHEID
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Scott A. Campbell: Corporate VP & CRO, VP, Clinical Affairs & CRO
Holdings: 0 shares
Latest Transaction: Nov 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott A. Campbell in CEPHEID
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 35.94 | 14,000 | 503,160 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 52.73 | 27,000 | 1,423,710 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 49.05 | 15,000 | 735,750 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 56.06 | 33,000 | 1,849,980 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 45.84 | 4,063 | 186,248 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 38.66 | 4,063 | 157,076 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 38.41 | 5,000 | 192,050 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | D | 0.00 | 7,000 | 0 | 0 | |
| Nov 07 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | D | 0.00 | 9,882 | 0 | 0 | 9.9 K to 0 (-100.00 %) |
| Oct 31 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 52.76 | 27 | 1,425 | 9,801 | 9.8 K to 9.8 K (-0.27 %) |
| Oct 24 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 52.80 | 27 | 1,426 | 9,828 | 9.9 K to 9.8 K (-0.27 %) |
| Sep 20 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 52.60 | 234 | 12,308 | 9,855 | 10.1 K to 9.9 K (-2.32 %) |
| Aug 17 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | S | 36.16 | 287 | 10,378 | 10,089 | 10.4 K to 10.1 K (-2.77 %) |
| Aug 17 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 36.50 | 130 | 4,745 | 10,376 | 10.5 K to 10.4 K (-1.24 %) |
| Aug 09 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | S | 37.57 | 157 | 5,899 | 10,506 | 10.7 K to 10.5 K (-1.47 %) |
| Aug 04 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | S | 36.19 | 58 | 2,099 | 10,663 | 10.7 K to 10.7 K (-0.54 %) |
| Aug 04 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | S | 36.75 | 688 | 25,284 | 10,721 | 11.4 K to 10.7 K (-6.03 %) |
| Aug 02 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 35.84 | 72 | 2,580 | 11,409 | 11.5 K to 11.4 K (-0.63 %) |
| Aug 02 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 35.33 | 27 | 954 | 11,481 | 11.5 K to 11.5 K (-0.23 %) |
| Jul 28 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
| Jul 28 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
| Jul 28 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
| Jul 25 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 32.90 | 27 | 888 | 11,357 | 11.4 K to 11.4 K (-0.24 %) |
| May 03 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Sell | S | 27.90 | 2,058 | 57,418 | 11,384 | 13.4 K to 11.4 K (-15.31 %) |
| May 03 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 28.45 | 286 | 8,137 | 13,442 | 13.7 K to 13.4 K (-2.08 %) |
| May 03 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 28.54 | 33 | 942 | 13,728 | 13.8 K to 13.7 K (-0.24 %) |
| May 03 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 28.54 | 27 | 771 | 13,761 | 13.8 K to 13.8 K (-0.20 %) |
| Apr 27 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | A | 35.94 | 14,000 | 503,160 | 14,000 | |
| Apr 25 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 34.98 | 28 | 979 | 13,788 | 13.8 K to 13.8 K (-0.20 %) |
| Feb 02 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 29.45 | 38 | 1,119 | 13,816 | 13.9 K to 13.8 K (-0.27 %) |
| Feb 02 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 29.45 | 31 | 913 | 13,854 | 13.9 K to 13.9 K (-0.22 %) |
| Jan 25 2016 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 32.68 | 31 | 1,013 | 13,765 | 13.8 K to 13.8 K (-0.22 %) |
| Nov 02 2015 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 33.40 | 33 | 1,102 | 13,796 | 13.8 K to 13.8 K (-0.24 %) |
| Nov 02 2015 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 34.27 | 27 | 925 | 13,829 | 13.9 K to 13.8 K (-0.19 %) |
| Oct 23 2015 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Payment of Exercise | F | 30.02 | 27 | 811 | 13,856 | 13.9 K to 13.9 K (-0.19 %) |
| Sep 21 2015 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Option Exercise | A | 52.73 | 27,000 | 1,423,710 | 27,000 | |
| Sep 21 2015 | CPHD | CEPHEID | Campbell Scott A. | Corporate VP & CRO | Grant | A | 0.00 | 3,000 | 0 | 13,883 | 10.9 K to 13.9 K (+27.57 %) |
| Aug 19 2015 | CPHD | CEPHEID | Campbell Scott A. | VP, Clinical Affair ... | Option Exercise | A | 49.05 | 15,000 | 735,750 | 15,000 | |
| Aug 19 2015 | CPHD | CEPHEID | Campbell Scott A. | VP, Clinical Affair ... | Grant | A | 0.00 | 1,667 | 0 | 10,883 | 9.2 K to 10.9 K (+18.09 %) |
Page: 1